Floatz logo

Idarubicine

Efficacy, Self

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Efficacy, Self cohort.

Asset / SponsorPhaseRating
Polyglucosamine Glucomannan High Dose
Heilpflanzenwohl AG
Phase 4BB
Polyglucosamine Glucomannan Normal Dose
Heilpflanzenwohl AG
Phase 4BB
Serplulimab
Sir Run Run Shaw Hospital
Phase 2CCC
Mitoxantrone
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2CCC
Nivolumab
Hospital Universitario Dr. Jose E. Gonzalez
Phase 2CCC
METHOTREXATE
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2CCC
Ifosfamide
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2CCC

Same molecule, other indications

Idarubicine is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
Acute Promyelocytic LeukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →